[1]梁冰,董铁立.miR-19a对慢性压迫性损伤大鼠神经病理性疼痛的影响及其机制[J].第三军医大学学报,2018,40(07):590-595.
　LIANG Bing,DONG Tieli.Effect of miR-19a on neuropathic pain in chronic constriction injury rats and its mechanism[J].J Third Mil Med Univ,2018,40(07):590-595.
点击复制

miR-19a对慢性压迫性损伤大鼠神经病理性疼痛的影响及其机制(/HTML )
分享到：

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
40卷
期数:
2018年第07期
页码:
590-595
栏目:
基础医学
出版日期:
2018-04-15

文章信息/Info

Title:
Effect of miR-19a on neuropathic pain in chronic constriction injury rats and its mechanism
作者:
梁冰; 董铁立
河南中医药大学第一附属医院麻醉科；郑州大学第二附属医院麻醉科
Author(s):
LIANG Bing;  DONG Tieli

Department of Anesthesiology, the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan Province, 450099；Department of Anesthesiology, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, 450014, China

关键词:
miR-19a; 慢性压迫性损伤; SOCS3; 机械性触诱发痛; 热痛觉过敏; 大鼠
Keywords:
miR-19a;  chronic constriction injury;  SOCS3;  mechanical touch-evoked pain;  thermal hyperalgesia;  rats
分类号:
R362.21; R394.3; R441.1
文献标志码:
A
摘要:

目的    观察miR-19a对慢性压迫性损伤（chronic constriction injury，CCI）大鼠神经病理性疼痛的作用，并探讨其潜在机制。方法    75只雄性SD大鼠按随机数字表法分为3组：假手术组，行假手术；CCI组，坐骨神经结扎法构建CCI大鼠模型；CCI+ inhibitor组，CCI大鼠鞘内注射miR19a inhibitor。于术前当天（0 d）和术后3、7、14、21 d观察机械缩足反射阈值（mechanical withdrawal threshold，MWT）和热刺激反射潜伏期（thermal withdrawal latency，TWL）的变化。采用RT-qPCR检测腰椎脊髓中促炎因子IL-6、TNF-α、IL-1β mRNA及JAK2和STAT3表达的变化，Western blot检测SOCS3蛋白水平的表达，荧光素酶报告基因技术验证miR-19a的靶基因。结果     与假手术组比较，CCI组大鼠脊髓的miR-19a表达显著上升（P<0.05），MWT显著降低，TWL显著缩短（P<0.05）。与CCI组比较，CCI+inhibitor组MWT显著升高，TWL显著延长（P<0.05）。RT-qPCR检测结果表明，CCI可显著促进促炎因子IL-6、TNF-α、IL-1β mRNA的表达；而与CCI组比较，CCI+inhibitor组IL-6、TNF-α、IL-1β mRNA表达水平均显著降低（P<0.05）。另一方面，与假手术组比较，CCI组大鼠术后脊髓中JAK2和STAT3 mRNA水平明显增加；与CCI组比较，CCI+inhibitor组术后脊髓中JAK2和STAT3的表达显著降低（P<0.01）。荧光素酶报告基因检测结果表明JAK2/STAT3上游的负调控因子SOCS3是miR-19a的靶基因。Western blot检测结果表明CCI组大鼠脊髓中SOCS3水平较假手术组升高，且SOCS3水平在CCI术后第7天达到最高，而后呈下降趋势；与CCI组比较，CCI+ inhibitor组SOCS3表达明显上升（P<0.05）。结论    miR-19a inhibitor能缓解CCI大鼠机械性触诱发痛和热痛觉过敏，该作用与SOCS3介导的JAK2/STAT3通路有关。

Abstract:

Objective    To determine the effect of miR-19a on neuropathic pain in rats and investigate the potential mechanisms. Methods     A rat model of chronic constriction injury (CCI) was established by sciatic nerve ligation. A total of 75 male SD rats were randomly divided into 3 groups, that is, sham group, CCI group, CCI+inhibitor group (intrathecal injection of miR-19a inhibitor). The mechanical withdrawal threshold (MWT) and thermal withdrawal latency (TWL) of each group were observed on the surgery day (regarded as 0 d) and 3, 7, 14 and 21 d post-operatively. Simultaneously, the mRNA expression levels of IL-6, TNF-α, IL-1β, JAK2 and STAT3 in the lumbar spinal cord were detected with RT-qPCR. Then, luciferase report gene assay was used to verify the target genes of miR-19a. Results     Compared to the sham group, miR-19a was highly expressed in the spinal cord tissue of CCI group (P<0.05), while MWT and TWL were significantly decreased (P<0.05). However, MWT and TWL were markedly increased in the CCI+inhibitor group when compared with the CCI group (P<0.05). What is more, RT-qPCR analysis showed that compared with the sham group, the pro-inflammatory factors, such as IL-6, TNF-α and IL-1β were highly increased in the CCI group, while they were decreased in the CCI+inhibitor group. Compared with the sham group, the mRNA expression levels of JAK2 and STAT3 were significantly enhanced in the spinal cord tissues of CCI rats, while inhibition of miR19a reversed these effects (P<0.05). Further luciferase assay identified that SOCS3, an upstream suppressor of JAK2/STAT3, was a target gene of miR-19a. Western blot assay showed the level of SOCS3 was highly expressed in the CCI group when compared with sham group, and it reached the highest at day 7 post-operatively. Compared with CCI group, the SOCS3 expression was markedly increased in CCI+inhibitor group (P<0.05). Conclusion     miR-19a inhibitor alleviates the mechanical withdrawal pain and thermal hyperalgesia, and this function is associated with SOCS3mediated JAK2/STAT3 pathway.

参考文献/References:

[1]WOOLF C J, MANNION R J. Neuropathic pain: aetiology, symptoms, mechanisms, and management[J]. Lancet, 1999, 353(9168): 1959-1964. DOI:10.1016/S0140-6736(99)01307-0.
[2]ARAI M, GENDA Y, ISHIKAWA M, et al. The miRNA and mRNA changes in rat hippocampi after chronic constriction injury[J]. Pain Med, 2013, 14(5): 720-729. DOI:10.1111/pme.12066.
[3]LPEZGONZLEZ M J, LANDRY M, FAVEREAUX A. MicroRNA and chronic pain: From mechanisms to therapeutic potential[J]. Pharmacol Ther, 2017, 180: 1-15. DOI:10.1016/j.pharmthera.2017.06.001.
[4]VON SCHACK D, AGOSTINO M J, MURRAY B S, et al. Dynamic changes in the microRNA expression profile reveal multiple regulatory mechanisms in the spinal nerve ligation model of neuropathic pain[J]. PLoS ONE, 2011, 6(3): e17670. DOI:10.1371/journal.pone.0017670.
[5]LIU M, WANG Z, YANG S, et al. TNFα is a novel target of miR19a[J]. Int J Oncol, 2011, 38(4): 1013-1022. DOI:10.3892/ijo.2011.924.
[6]BENNETT G J, XIE Y K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man[J]. Pain, 1988, 33(1): 87-107. DOI:10.1016/0304-3959(88)90209-6.
[7]CHEN H, LI X, LIU S, et al. MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis[J]. Sci Rep, 2017, 7(1): 12089. DOI:10.1038/s41598-017-12167-z.
[8]SAKAI A, SAITOW F, MARUYAMA M, et al. MicroRNA cluster miR-17-92 regulates multiple functionally related voltage-gated potassium channels in chronic neuropathic pain[J]. Nat Commun, 2017, 8: 16079. DOI:10.1038/ncomms16079.
[9]LIU S, MI W L, LI Q, et al. Spinal IL-33/ST2 signaling contributes to neuropathic pain via neuronal CaMKII-CREB and astroglial JAK2-STAT3 cascades in mice[J]. Anesthesiology, 2015, 123(5): 1154-1169. DOI:10.1097/ALN.0000000000000850.
[10]WANG Z F, LI Q, LIU S B, et al. Aspirin-triggered Lipoxin A4 attenuates mechanical allodynia in association with inhibiting spinal JAK2/STAT3 signaling in neuropathic pain in rats[J]. Neuroscience, 2014, 273: 65-78. DOI:10.1016/j.neuroscience.2014.04.052.
[11]DOMINGUEZ E, MAUBORGNE A, MALLET J, et al. SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury[J]. J Neurosci, 2010, 30(16): 5754-5766. DOI:10.1523/JNEUROSCI.500709.2010.
[12]DUBOVY P, KLUS-KOV- I, SV-ZENSK- I, et al. Satellite glial cells express IL-6 and corresponding signaltransducing receptors in the dorsal root ganglia of rat neuropathic pain model[J]. Neuron Glia Biol, 2010, 6(1): 73-83. DOI:10.1017/S1740925X10000074.
[13]LI D, YAN Y, YU L, et al. Procaine attenuates pain behaviors of neuropathic pain model rats possibly via inhibiting JAK2/STAT3[J]. Biomol Ther (Seoul), 2016, 24(5): 489-494. DOI:10.4062/biomolther.2016.006.
[14]LIU S, LI Q, ZHANG M T, et al. Curcumin ameliorates neuropathic pain by downregulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling[J]. Sci Rep, 2016, 6: 28956. DOI:10.1038/srep28956.
[15]HORIGUCHI A, ASANO T, KURODA K, et al. STAT3 inhibitor WP1066 as a novel therapeutic agent for renal cell carcinoma[J]. Br J Cancer, 2010, 102(11): 1592-1599. DOI:10.1038/sj.bjc.6605691.
[16]BABON J J, KERSHAW N J, Murphy J M, et al. Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity[J]. Immunity, 2012, 36(2): 239-250. DOI:10.1016/j.immuni.2011.12.015.
[17]BABON J J, VARGHESE L N, NICOLA N A. Inhibition of IL-6 family cytokines by SOCS3[J]. Semin Immunol, 2014, 26(1): 13-19. DOI:10.1016/j.smim.2013.12.004.
[18]LATR-MOLI-RE A, MAUBORGNE A, MASSON J, et al. Differential implication of proinflammatory cytokine interleukin6 in the development of cephalic versus extracephalic neuropathic pain in rats[J]. J Neurosci, 2008, 28(34): 8489-8501. DOI:10.1523/JNEUROSCI.255208.2008.
[19]BRUMANN M, MATZ M, KUSMENKOV T, et al. Impact of STAT/SOCS mRNA expression levels after major injury[J]. Mediators Inflamm, 2014, 2014: 749175. DOI:10.1155/2014/749175.
[20]XUE Z J, SHEN L, WANG Z Y, et al. STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats[J]. Brain Res, 2014, 1583: 79-88. DOI:10.1016/j.brainres.2014.07.015.
[21]BAKER B J, AKHTAR L N, BENVENISTE E N. SOCS1 and SOCS3 in the control of CNS immunity[J]. Trends Immunol, 2009, 30(8): 392-400. DOI:10.1016/j.it.2009.07.001.
[22]QIN H, YEH W I, DE SARNO P, et al. Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation[J]. Proc Natl Acad Sci U S A, 2012, 109(13): 5004-5009. DOI:10.1073/pnas.1117218109.

更新日期/Last Update: 2018-04-10